China's demand for new vaccines will reach 800 billion

2013-05-03 source: Fu Mingzhong, executive chairman of China Pharmaceutical Business Association, Shanghai Securities News, predicted at the 69th pharmaceutical fair that the biomedical industry is expected to form a market of 600 billion to 800 billion yuan in the future, and its rapid growth is brought by the needs of various segments First of all, there is a strong demand for new vaccines in the market, and the ability to prevent and control major infectious diseases can generate a vaccine market of 100 billion to 150 billion yuan in scale; second, the market of biotechnology drugs such as antibody drugs and protein drugs can generate 300 billion to 500 billion yuan in the future; major disease diagnosis and detection technology products will form 50 billion yuan A market of about 100 billion yuan; personalized treatment drugs are expected to form a market of about 100 billion yuan; the market of regenerative medical technology, such as organ deficiency, can form a market of at least 50 billion yuan for regenerative treatment and rehabilitation Zhu Jianying, chief analyst of China Pharmaceutical Industry Information Center, said that from the perspective of various micro industries in the pharmaceutical market in 2012, the biological products industry is one of the most profitable sub industries in the pharmaceutical industry In 2012, the sales revenue of biopharmaceutical manufacturing industry was 177.543 billion yuan, an increase of 18.84% year on year; the total profit was 23.013 billion yuan, an increase of 14.3% year on year.